Biotech · Private company
Crossbow Therapeutics, Inc.
Track this companyFree. Adds Crossbow Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials22 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- CBX-250Phase 1 · High-risk Myelodysplastic SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- CBX-663Phase 1 · Advanced Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- A Phase 1, Open-Label, Dose-Escalation Study to Evaluate Safety, Tolerability, and Clinical Activity of CBX-663 in Participants With Relapsed or Refractory Myeloid Malignancies, Advanced Solid Tumors, or Recurrent or Progressive Glioblastoma.PHASE1 · RECRUITING · started Aug 4, 2026ClinicalTrials.gov NCT07779798 · fetched Nov 12, 2026
- A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid LeukemiasPHASE1 · RECRUITING · started Jul 16, 2025ClinicalTrials.gov NCT06994676 · fetched Nov 12, 2026